
drug development
-
-
Artificial Intelligence Biotechnology Clinical Research Digital Health FDA Matthew Chun Medical Safety Pharmaceuticals Student Fellows Transparency
FDA Solicits Feedback on the Use of AI and Machine Learning in Drug Development
Read more: FDA Solicits Feedback on the Use of AI and Machine Learning in Drug Development -
Arthur Caplan Bioethics FDA Health Law Policy Human Subjects Research Market Design Medical Quality Medical Safety Patient Care Pharmaceuticals Professional Regulation Public Health Scientific Evidence
Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal
Read more: Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal -
Excluding Pregnant People From Clinical Trials Reduces Patient Safety and Autonomy
Read more: Excluding Pregnant People From Clinical Trials Reduces Patient Safety and Autonomy -
Year in Review: Biosimilars
Read more: Year in Review: Biosimilars